When was Unlearn founded?

Unlearn was founded in 2017 and raised its 1st funding round 3 years after it was founded.

Where is Unlearn located?

Unlearn is headquartered in San Francisco, United States.

How many employees does Unlearn have?

As of Mar 31, 2026, the latest employee count at Unlearn is 71.

Is Unlearn a funded company?

Unlearn is a funded company, having raised a total of $135M across 6 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jan 30, 2020.

How much is Unlearn worth?

The latest valuation of Unlearn is $***** as of Mar 21, 2023.

When was the latest funding round of Unlearn?

Unlearn's latest funding was a $***** Series C round on Jan 25, 2024, with participation from 9 investors.

Where does Unlearn rank among its competitors?

Unlearn ranks 1st amongst 30 active competitors, of which 16 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Ryght, which secured an undisclosed amount in Dec, 2025.

Who are the top competitors of Unlearn?

Unlearn's top competitors include Ryght, Electric Twin and Ebenbuild. Among them, Ryght secured the most recent funding round in December, 2025.

Unlearn - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of an AI platform for clinical trial design and analysis. The platform provides tools for trial design, literature review, data exploration, and scenario building. It offers digital twins to forecast clinical trial participant outcomes. The platform aims to improve decision-making and efficiency in clinical development.

Website: www.unlearn.ai/
Social

Key Metrics

Founded Year

2017

Location

San Francisco, United States

Stage

Series C

Total Funding

$135M in 6 rounds

Latest Funding Round

Series C, Jan 25, 2024, $*****

Post Money Valuation

$***** as on Mar 21, 2023

Investors

Insight Partners & 15 more

Ranked

1^st among 30 active competitors

Employee Count

71 as on Mar 31, 2026

Similar Companies

Innovaccer & 2345 more

View Unlearn's full profile

Unlearn has raised a total funding of $135M over 6 rounds. Its first funding round was on Jan 30, 2020. Its latest funding round was a Series C round on Jan 25, 2024 for $*****. 9 investors participated in its latest round. Unlearn has 15 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Unlearn:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 25, 2024	1133469	Series C	8092621	9490471	7777792	1092002
Mar 21, 2023	8355338	Series B	8473900	8915032	4567150	2939547
Apr 18, 2022	8628404	Series B	6930164	5894295	Global Ventures & 1 more	Radical Ventures & 4 more

Access funding benchmarks and valuations. Sign up today!

View details of Unlearn's funding rounds and investors

The founders of Unlearn are Charles Fisher and Jonathan Walsh. Steven Herne is the CEO of Unlearn.

Here are the details of Unlearn's key team members:

Charles Fisher: Former Co-Founder of Unlearn and founder of 1 other company. They serve on the boards of 2 companies.
Jonathan Walsh: Founder, VP of Technology of Unlearn.
Contact Info: 1 email address
Steven Herne: CEO of Unlearn.
Contact Info: 1 email address

View details of Unlearn's Founder profiles and Board Members

Unlearn's employee count trend

Unlearn has 71 employees as of Mar 26. Here is Unlearn's employee count trend over the years:

Uncover Unlearn's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Unlearn include Ryght, Electric Twin and Ebenbuild. Here is the list of Top 10 competitors of Unlearn, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Unlearn 2017, San Francisco (United States), Series C	Developer of an AI platform for clinical trial design and analysis	$135M	Mubadala, Altimeter Capital & 14 others	65/100
2nd	Ryght 2023, Anaheim (United States), Series A	Generative AI platform focused on biopharma smart biomedical data	$8.57M	Virtue, Foothill Ventures & 3 others	55/100
3rd	Electric Twin 2020, London (United Kingdom), Series A	AI-powered digital twin technology for research and clinical applications in the life sciences industry	$14M	Atomico, LocalGlobe & 5 others	52/100
4th	Ebenbuild 2018, Munich (Germany), Seed	Provider of digital twin-based precision therapy solution	$2.78M	Bayern Kapital, HTGF & 2 others	50/100
5th	ELEM Biotech 2018, Barcelona (Spain), Seed	Provider of a simulation based platform for doctors	$2.27M	GENESIS Biomed, EIC Fund & 1 others	43/100
6th	Verto Health 2017, Toronto (Canada), Seed	Provider of AI-based digital twin platform for population health management	$1.52M	MaRS IAF, OneEleven & 4 others	42/100
7th	Virtonomy 2019, Munich (Germany), Seed	Provider of virtual patient simulation for medical device development	$3.82M	Dieter von Holtzbrinck Ventures, Accenture ... & 11 others	39/100
8th	Adsilico 2022, London (United Kingdom), Seed	Provider of insilico trials using virtual patients to assess medical device safety	$4.56M	Parkwalk, Northern Gritstone & 2 others	36/100
9th	Precision Diagnosis Technology Series B	Provider of digital twin technology for precision medicine	$15.5M	Zhiyou Scientist Fund, Qirong Venture Capital	34/100
10th	Akkure 2016, Dublin (Ireland), Seed	Provider of a blockchain technology based online platform for genomic data analytics	$3.37M	Enterprise Ireland, Digital Transformation Innovation Fund ... Read more	32/100